✨ New in 2024: the Global Patient Survey on #kidneycancer will explore new topics including time to diagnosis, treatment adherence to oral therapies, kidney function and patient preferences. Share your insights today. https://bit.ly/ikcc2024GPS International Kidney Cancer Coalition (IKCC)
EKPF - European Kidney Patients' Federation’s Post
More Relevant Posts
-
GLOBAL PATIENT SURVEY ON KIDNEY CANCER The 2024 survey explores new topics including time to diagnosis, treatment adherence to oral therapies, kidney function and patient preferences. Share your insights today: https://bit.ly/ikcc2024GPS #kidneycancer #cancerdurein International Kidney Cancer Coalition (IKCC)
-
-
Here you have the chance to contribute to shaping the 🇪🇺guidelines an colorectal (bowel) cancer screening and diagnosis #ECICC.
❔ Have you ever wondered if you can contribute to the European guidelines on cancer screening? 💡 We are collecting feedback on several aspects of colorectal cancer prevention, screening and diagnosis. 👆 Share your views on research protocols and the list of healthcare questions: https://lnkd.in/eDMWkzvM ⌚ Deadline: 7 November 2024 #ECICC, EU Science, Research and Innovation, #PublicHealth, #EuropeanCommissionInitiativeonColorectalCancer
-
-
Managed by Simon Malia, Communications Manager at Roy Castle Lung Cancer Foundation
Excellent, in-depth overview of the historical development of lung cancer research and healthcare.
Our Ambition, Improvement, Measurement (AIM) programme is made up of four reports to address the current challenges of #LungCancer management and provide recommendations to improve patient outcomes. A recently published News Medical article, discusses these AIM reports and spotlights how they can support HCPs in tackling lung cancer challenges and our continued work to eliminate lung cancer as a cause of death. To learn more about these reports and the LAA’s work, read the article here: https://bit.ly/LCNM
-
Oncologist, Professor of Medicine at University of Leipzig, Head of Medical Oncology, Director of the Comprehensive Cancer Center Central Germany
View the latest update of the ESMO Gastric Cancer Living Guidelines online #Esmo #GastricCancer #Guidelines https://lnkd.in/dVDEAJGA
-
🔔 In this episode of 🎙️ #OncLiveOnAir 🎙️, Sandip Patel, M.D. and Brendon Stiles, MD, of UC San Diego Health and Montefiore Health System, discuss the significance of the FDA approval of perioperative durvalumab for patients with resectable non–small cell lung cancer. Listen here 🎧: https://lnkd.in/ei4xTswv
-
-
Pancreatic cancer patients who participate in clinical research have better outcomes. That's why we strongly recommend that all patients consider clinical trials at diagnosis and during every treatment decision. 💜 We maintain the most comprehensive and up-to-date database of #pancreaticcancer clinical trials available in the U.S. and can help you or a loved one find a trial that's right for you. Learn more at ➡️ pancan.org/clinicaltrials
-
-
OncoZenge AB(publ) Determined to bring effective, non-opioid, oral pain relief to the patients.
Brief article about OncoZenge!
Our CEO Stian Kildal recently spoke to John Sundström about our opportunity to significantly improve Quality of Life for cancer patients going through radio- and chemotherapy. An impending decision on development partner for the pivotal phase 3 project for Europe will in turn enable commercialization partners. And with it a path to the market and the patients who need it. Read and share! (Note: Swedish) 🔗 👇 https://lnkd.in/d9eb-mDR
-
-
Enhance your gastric cancer care with short videos from leading experts! Discover key biomarker insights and treatment options in a flash. #GastricCancer #Biomarkers Start watching: https://ow.ly/rl3N50TOBFu
-
-
Long-term relative survival of patients with gastric cancer from a large-scale cohort: a period-analysis https://lnkd.in/e4xdkqCG 🧪 @BioMedCentral #CancerResearch
-
-
Through clinical trials, doctors determine whether new treatments are safer and more effective than current treatments. These trials help us find new ways to prevent and detect cancer to improve the quality of life during and after treatment, but also redefine cancer care for future patients. Today, people are living longer lives from successful cancer treatments that are the results of past clinical trials. Support the care of tomorrow: https://bit.ly/4bEsCrO
-
